Diseases of the adrenal medulla

Acta Physiologica

Volumn 192, Issue 2, 2008, Pages 325-335

  Fung, M M ^a   Viveros, O H ^a   O'Connor, D T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenal; Catecholamine; Chromaffin; Phaeochromocytoma

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMIODARONE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHROMOGRANIN A; CORTICOTROPIN; DESIPRAMINE; DOXAZOSIN; HISTAMINE; LABETALOL; LIDOCAINE; METADRENALIN; METIROSINE; METOCLOPRAMIDE; METOPROLOL; NALOXONE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENOXYBENZAMINE; PHENTOLAMINE; PRAZOSIN; SULPIRIDE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADRENAL MEDULLA DISEASE; ADRENERGIC SYSTEM; ALGORITHM; ANXIETY; BLOOD CHEMISTRY; BLOOD FLOW; BLOOD PRESSURE REGULATION; CATECHOLAMINE RELEASE; CHROMAFFIN GRANULE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DIAPHORESIS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DRUG DOSE TITRATION; EJACULATION DISORDER; EXOCYTOSIS; EXTRAPYRAMIDAL SYNDROME; FAMILIAL DISEASE; FATIGUE; GANGLIONEUROMA; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; INNATE IMMUNITY; NEUROBLASTOMA; NOSE CONGESTION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; PARAGANGLIOMA; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PHEOCHROMOCYTOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SEDATION; SIDE EFFECT; SIPPLE SYNDROME; TACHYCARDIA; TREATMENT CONTRAINDICATION; URINALYSIS; XEROSTOMIA;

ADRENAL CORTEX NEOPLASMS; ADRENAL GLAND DISEASES; ADRENAL MEDULLA; AUTONOMIC NERVOUS SYSTEM DISEASES; CATECHOLAMINES; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEUROBLASTOMA; PARAGANGLIOMA; PHEOCHROMOCYTOMA;

EID: 38549131692     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2007.01809.x     Document Type: Conference Paper

References (33)

1. Benn, D.E., Gimenez-Roqueplo, A.P., Reilly, J.R. et al. 2006. Clinical presentation and penetrance of phaeochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 91, 827 836.
2. Bravo, E.L., Tarazi, R.C., Fouad, F.M. et al. 1981. Clonidine suppression test: a useful aid in the diagnosis of phaeochromocytoma. N Engl J Med 305, 623 626.
3. Brouwers, F.M., Eisenhofer, G., Lenders, J.W.M. Pacak, K. 2006. Emergencies caused by phaeochromocytoma, neuroblastoma, or ganglioma. Endocrinol Metab Clin N Am 35, 699 724.
4. Erickson, D., Kudva, Y.C., Ebersold, M.J. et al. 2001. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 86, 5210 5216.
5. Geoerger, B., Hero, B., Harms, D., Grebe, J., Scheldhauer, K. Berthold, F. 2001. Metabolic activity and clinical features of primary ganglioneuromas. Cancer 91, 1905 1913.
6. Giminez-Roquelo, A.P., Lehnert, H., Mannelli, M. et al. 2006. Phaeochromocytoma, new genes and screening strategies. Clin Endocrinol 65, 699 705.
7. Gozes, I., O'Connor, D.T. Bloom, F.E. 1983. A possible high molecular weight precursor to vasoactive intestinal polypeptide sequestered into phaeochromocytoma chromaffin granules. Regul Pept 6, 111 119.
8. Havekes, B., Corssmit, E.P.M., Jansen, J.C., van der Mey, A.G.L., Vriends, A.H.J.T. Romijn, J.A. 2007. Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. J Clin Endocrinol Metab [epublished ahead of print.]
9. Hsiao, R.J., Neumann, H.P.H., Parmer, R.J., Barbosa, J.A. O'Connor, D.T. 1990a. Chromogranin A in familial phaeochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution. Am J Med 88, 607 613.
10. Hsiao, R.J., Mezger, M.S. O'Connor, D.T. 1990b. Chromogranin A in uremia: progressive retention of immunoreactive fragments. Kidney Int 37, 955 964.
11. Hsiao, R.J., Seeger, R.C., Yu, A.L. O'Connor, D.T. 1990c. Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival. J Clin Invest 85, 1555 1559.
12. Hsiao, R.J., Parmer, R.J., Takiyyuddin, M.A. O'Connor, D.T. 1991. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of phaeochromocytoma. Medicine (Baltimore) 70, 33 45.
13. Ilias, I., Yu, J., Carrasquillo, J.A. et al. 2003. Superiority of 6-[18-F] fluorodopamine positron emission tomography versus [131-I] metaiodobenzylguanidine scintigraphy in the localization of metastatic phaeochromocytoma. J Clin Endocrinol Metab 88, 4080 4087.
14. Kailasam, M.T., Parmer, R.J., Stone, R.A. et al. 1995. Factitious phaeochromocytoma: novel mimickry by valsalva manuever and clues to diagnosis. Am J Hypertens 8, 651 655.
15. Ketch, T., Biaggioni, I., Robertson, R. Robertson, D. 2002. Four faces of baroreflex failure: hypertensive crisis, volatile hypertension, orthostatic tachycardia, and malignant vagotonia. Circulation 105, 2518 2523.
16. Kim, C.H., Zabetian, C.P., Cubells, J.F. et al. 2002. Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency. Am J Med Genet 108, 140 147.
17. Lau, S.K., Romansky, S.G. Weiss, L.M. 2006. Sustentaculoma: report of a case of a distinctive neoplasm of the adrenal medulla. Am J Surg Pathol 30, 268 273.
18. Lenders, J.W.M., Pacak, K., Walther, M.M. et al. 2002. Biochemical diagnosis of phaeochromocytoma: which test is best? JAMA 287, 1427 1434.
19. Maxwell, P.H. 2005. A common pathway for genetic events leading to phaeochromocytoma. Cancer Cell 8, 91 93.
20. Neumann, H.P.H., Bausch, B., McWhinney, S.R. et al. 2002. Germ-line mutations in nonsyndromic phaeochromocytoma. N Engl J Med 346, 1459 1466.
21. O'Connor, D.T. 2003. The adrenal medulla, catecholamines, and phaeochromocytoma. In : R.L. Cecil, L. Goldman D.A. Ausiello (eds) Cecil's Textbook of Medicine, pp. 1419 1424. Saunders, Philadelphia, PA.
22. O'Connor, D.T. Gochman, N. 1983. Lactic dehydrogenase activity in human phaeochromocytoma. JAMA 249, 383 385.
23. O'Connor, D.T., Frigon, R.P. Deftos, L.J. 1983. Immunoreactive calcitonin in catecholamine storage vesicles of human phaeochromocytoma. J Clin Endocrinol Metab 56, 582 585.
24. Opochner, G., Schiavi, F., Iacobone, M. et al. 2006. Familial nonsyndromic phaeochromocytoma. Ann NY Acad Sci 1073, 149 155.
25. Pacak, K., Eisenhofer, G., Ahlman, H. et al. 2007. Phaeochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab 3, 92 102.
26. Parmer, R.J. O'Connor, D.T. 1988. Enkephalins in human phaeochromocytomas: localization in immunoreactive, high molecular weight form to the soluble core of chromaffin granules. J Hypertens 6, 187 198.
27. Rao, F., Keiser, H.R. O'Connor, D.T. 2000. Malignant phaeochromocytoma. Chromaffin granule transmitters and response to treatment. Hypertension 36, 1045 1052.
28. Reisch, N., Peczkowska, M., Januszewicz, A. Neumann, H.P.H. 2006. Phaeochromocytoma: presentation, diagnosis, and treatment. J Hypertens 24, 2331 2339.
29. Sawka, A.M., Jaeschke, R., Singh, R.J. Young, W.F. 2003. A comparison of biochemical tests for phaeochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88, 553 558.
30. Schiavi, F., Boedeker, C.C., Bausch, B. et al. 2005. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 294, 2057 2063.
31. Scholz, T., Eisenhofer, G., Pacak, K., Dralle, H. Lehnert, H. 2007. Current treatment of malignant phaeochromocytoma. J Clin Endocrinol Metab 92, 1217 1225.
32. Singh, R.J. 2004. Advances in metanephrine testing for the diagnosis of phaeochromocytoma. Clin Lab Med 24, 85 103.
33. Taupenot, L., Harper, K.L. O'Connor, D.T. 2003. The chromogranin- secretogranin family. N Engl J Med 348, 1134 1149.